Sleep loss leads to negativity bias, negative mood and impaired emotional regulation.
Researchers have discovered a new method that can predict a person's current level of awareness and whether they will recover awareness within a year of a TBI.
A new neuroimaging test could help doctors identify CTE in those exposed to repetitive brain injuries, such as NFL players, a new study reports.
Males on the autism spectrum have significantly lower levels of a protein in their brains' that plays a role in inflammation and metabolism.
A new neuroimaging study links alcohol cravings to the right ventral striatum.
Researchers have been able to restore consciousness to a patient who has been in a vegetative state for 15 years. The groundbreaking study utilized vagus nerve stimulation to help restore consciousness to the patient.
PET imaging that helps detect dementia-related amyloid plaques significantly influences the clinical management of patients, a new study reports.
Women with the ApoE e4 genetic risk factor for Alzheimer's are more susceptible to tau accumulation in the brain than men.
According to researchers, it may soon be possible to diagnose Alzheimer's disease during a simple eye exam. The study reports those with elevated amyloid and tau levels have significant thinning at the center of the retina.
A new, non-invasive brain stimulation treatment shows promise in enhancing memories and cognitive function in those with Alzheimer's disease. Transcranial electromagnetic treatment (TEMT) increases functional connectivity within the cingulate cortex. TEMT is also able to penetrate the brain to break up amyloid-beta and tau deposits, slowing the progression of Alzheimer's disease.
Researchers discover amyloid accumulation is greater on the left side of the brain with many individuals living with PPA.
Blood samples taken from people enrolled in an Alzheimer's research study revealed higher levels of phosphorylated tau 217 that correlated with the presence of amyloid plaques. People with amyloid in their brains had up to three times more of the tau protein in their blood than those who had no evidence of amyloid accumulation. The higher levels of the protein were evident even in people with no signs of cognitive decline.